OncoCam Science of Oncology

វិទ្យសាស្ត្រអភិវដ្ឍន៏ វេជ្ជសាស្ត្រកាន់តែទំនើប កាន់តែជួយសម្រាលទុក្ខដល់អ្នកជម្ងឺមហារីក រួមទាំងមហារីកឈាម នឹងនហារីកទូទៅ។ តេស...
19/01/2025

វិទ្យសាស្ត្រអភិវដ្ឍន៏ វេជ្ជសាស្ត្រកាន់តែទំនើប កាន់តែជួយសម្រាលទុក្ខដល់អ្នកជម្ងឺមហារីក រួមទាំងមហារីកឈាម នឹងនហារីកទូទៅ។

តេស្តថ្មី ផ្តោតលើ ករណី ខ្សោយខួរឆ្អឹង ឬមានបងប្អូនខ្សែរស្រឡាយដែលឈឺ (Inherited Bone Marrow Failure)

ក្តីសង្ឈឹមថ្មី ជាមួយបច្ចេកទេសវេជ្ជសាស្ត្រទំនើប❤️
New hope with modern technology in medicine

23/11/2024

5. Cancer Symptoms and Side Effects

• Cachexia: Severe weight loss and muscle wasting associated with advanced cancer.
• Paraneoplastic Syndromes: Symptoms caused by substances produced by the tumor, not the tumor’s physical presence.
• Neutropenia: A low level of neutrophils, increasing infection risk, often caused by chemotherapy.
• Alopecia: Hair loss, a common side effect of chemotherapy.

6. Monitoring and Prognosis

• Recurrence: Return of cancer after treatment and a period of remission.
• Remission: Reduction or disappearance of signs of cancer; can be partial or complete.
• Survival Rate: Percentage of people who survive a certain type of cancer for a specified period.
• Progression-Free Survival (PFS): Time during and after treatment in which the disease does not worsen.

23/11/2024

Molecular and Genetic Terms

• Oncogene: A gene that has the potential to cause cancer when mutated or overexpressed.
• Tumor Suppressor Gene: A gene that prevents uncontrolled cell growth; mutations inactivate its function (e.g., TP53).
• Biomarker: A measurable substance in the body indicating the presence or behavior of cancer (e.g., PSA for prostate cancer).
• Driver Mutations: Genetic changes that contribute directly to cancer progression.

22/11/2024

+ Treatment Modalities

• Chemotherapy: Use of drugs to destroy cancer cells or slow their growth.
• Radiation Therapy: Use of high-energy radiation to kill or damage cancer cells.
• Immunotherapy: Boosting the immune system to recognize and destroy cancer cells.
• Targeted Therapy: Drugs that target specific molecules involved in cancer growth.
• Surgery: Physical removal of the tumor and sometimes surrounding tissues.
• Hormone Therapy: Blocking hormones that fuel certain cancers (e.g., breast or prostate cancer).

22/11/2024

+ Diagnosis and Staging

• Biopsy: Removal of a sample of tissue for microscopic examination to diagnose cancer.
• Imaging Studies: Techniques like CT, MRI, PET scans, and X-rays used to visualize tumors.
• TNM Staging: A system to describe cancer stages:
• T (Tumor): Size and extent of the primary tumor.
• N (Node): Spread to nearby lymph nodes.
• M (Metastasis): Spread to distant organs.
• Grade: A measure of how much cancer cells differ from normal cells, indicating aggressiveness.

21/11/2024

In oncology, precise terminology is essential for understanding, diagnosing, and treating cancer. Below is an overview of common terms and concepts used in the field:

+ General Cancer Terms

• Oncology: The branch of medicine dealing with the prevention, diagnosis, and treatment of cancer.
• Tumor (Neoplasm): An abnormal growth of cells that can be benign (non-cancerous) or malignant (cancerous).
• Carcinoma: A cancer that begins in the epithelial cells lining the skin or internal organs.
• Sarcoma: Cancer originating in bone, cartilage, fat, muscle, or connective tissue.
• Lymphoma: Cancer of the lymphatic system.
• Leukemia: Cancer of the blood-forming tissues, like the bone marrow.
• Metastasis: Spread of cancer cells from the primary tumor to other parts of the body.

21/11/2024

Oncology is the branch of medicine that specializes in the diagnosis, treatment, and study of cancer. Doctors who practice oncology are called oncologists.

Types of Oncology

1. Medical Oncology: Focuses on the use of medications like chemotherapy, immunotherapy, and targeted therapy to treat cancer.
2. Radiation Oncology: Uses radiation therapy to destroy cancer cells.
3. Surgical Oncology: Involves the surgical removal of tumors or cancer-affected areas.
4. Pediatric Oncology: Specializes in treating cancer in children.
5. Hematology-Oncology: Deals with blood cancers like leukemia, lymphoma, and multiple myeloma.

Common Responsibilities in Oncology

• Diagnosing cancer through tests such as biopsies, imaging, and blood work.
• Determining the stage of cancer to guide treatment.
• Creating personalized treatment plans for patients.
• Providing follow-up care and monitoring for cancer recurrence.

Would you like more details on a specific type of oncology or its treatments?

24/09/2024

Anemia is a condition characterized by a deficiency in the number or quality of red blood cells or hemoglobin, which impairs the blood's ability to carry oxygen to the body's tissues. This can lead to symptoms such as fatigue, weakness, pale skin, and shortness of breath. Here's a detailed overview of anemia:
Types of Anemia:
1. Iron-Deficiency Anemia:
o Cause: Insufficient iron to produce hemoglobin.
o Common Causes: Poor diet, chronic blood loss (e.g., from menstruation or gastrointestinal bleeding), or impaired iron absorption.
2. Vitamin-Deficiency Anemia:
o Cause: Deficiencies in vitamins such as B12 or folate.
o Common Causes: Poor dietary intake, malabsorption conditions (e.g., pernicious anemia), or certain medications.
3. Anemia of Chronic Disease:
o Cause: Chronic inflammation or disease (e.g., chronic kidney disease, rheumatoid arthritis) that affects red blood cell production.
o Mechanism: Inflammation can interfere with iron metabolism and erythropoiesis.
4. Aplastic Anemia:
o Cause: The bone marrow fails to produce sufficient red blood cells.
o Common Causes: Autoimmune diseases, exposure to toxins or certain medications, or genetic disorders.
5. Hemolytic Anemia:
o Cause: Destruction of red blood cells faster than they can be produced.
o Common Causes: Autoimmune diseases, genetic disorders (e.g., sickle cell disease), or infections.
6. Sickle Cell Anemia:
o Cause: A genetic mutation causes red blood cells to become rigid and sickle-shaped.
o Common Complications: Pain episodes, anemia, organ damage, and increased risk of infection.
7. Thalassemia:
o Cause: Genetic mutations affect hemoglobin production.
o Common Complications: Severe anemia, organ damage due to iron overload, and growth issues.
Symptoms:
• Fatigue
• Weakness
• Pale or yellowish skin
• Shortness of breath
• Dizziness or lightheadedness
• Cold hands and feet
• Chest pain (in severe cases)
Diagnosis:
• Complete Blood Count (CBC): Measures red blood cell count, hemoglobin, hematocrit, and other parameters.
• Iron Studies: Includes serum iron, ferritin, and transferrin levels.
• Vitamin Levels: B12 and folate levels.
• Bone Marrow Biopsy: In cases of aplastic anemia or if the cause is unclear.
• Hemoglobin Electrophoresis: To diagnose conditions like sickle cell anemia and thalassemia.
Treatment:
• Iron-Deficiency Anemia: Iron supplements, dietary changes, and addressing the underlying cause of blood loss.
• Vitamin-Deficiency Anemia: Vitamin B12 or folate supplements.
• Anemia of Chronic Disease: Treating the underlying disease or condition.
• Aplastic Anemia: Blood transfusions, medications, or bone marrow transplantation.
• Hemolytic Anemia: Addressing the underlying cause, possibly using medications to suppress the immune system.
• Sickle Cell Anemia: Pain management, hydration, blood transfusions, and medications like hydroxyurea.
• Thalassemia: Blood transfusions, iron chelation therapy, and in severe cases, bone marrow transplantation.
Prevention and Management:
• Diet: Ensure adequate intake of iron, vitamins B12, and folate.
• Regular Check-ups: Monitor for chronic conditions that could lead to anemia.
• Screening: For at-risk populations, such as pregnant women and individuals with chronic diseases.
• Education: Awareness about symptoms and timely medical consultation.

Acute Promyelocytic Leukemia (APL) is a subtype of Acute Myeloid Leukemia (AML) characterized by the accumulation of pro...
20/09/2024

Acute Promyelocytic Leukemia (APL) is a subtype of Acute Myeloid Leukemia (AML) characterized by the accumulation of promyelocytes, a type of immature white blood cell, in the bone marrow and blood. APL is distinct due to its specific clinical features and genetic abnormalities, and it requires targeted treatment approaches.
Characteristics:
• Promyelocytes: These are immature myeloid cells that appear in large numbers in the bone marrow and peripheral blood.
• Genetic Abnormality: APL is often associated with the t(15;17) chromosomal translocation, resulting in the PML-RARA fusion gene. This genetic abnormality disrupts normal blood cell differentiation and contributes to the leukemic process.
Symptoms:
• Hematological Symptoms: Patients may experience bleeding due to coagulopathy, which can lead to easy bruising, bleeding gums, and frequent nosebleeds.
• General Symptoms: Fatigue, fever, weight loss, and bone pain.
• Complications: Increased risk of bleeding complications, including bleeding in the brain or internal organs.
Diagnosis:
1. Blood Tests:
o Complete Blood Count (CBC): Shows elevated white blood cell count with a high proportion of promyelocytes.
o Peripheral Blood Smear: Identifies characteristic promyelocytes with bundles of rod-shaped granules (also known as "bundle-of-figs" appearance).
2. Bone Marrow Biopsy:
o Confirms the diagnosis by revealing promyelocytes and the extent of bone marrow involvement.
3. Genetic Testing:
o Detects the PML-RARA fusion gene, which is crucial for confirming APL and guiding treatment.
4. Cytogenetic Analysis:
o Examines chromosomal abnormalities, including the t(15;17) translocation.
5. Immunophenotyping:
o Flow Cytometry: Used to analyze cell surface markers and confirm the subtype of leukemia.
Treatment:
1. All-Trans Retinoic Acid (ATRA):
o Mechanism: ATRA induces differentiation of promyelocytes into mature cells and is a cornerstone of APL treatment.
o Administration: Given orally or intravenously.
2. Arsenic Trioxide (ATO):
o Mechanism: Targets and destroys promyelocytes and is used in combination with ATRA for improved outcomes.
o Administration: Given intravenously.
3. Chemotherapy:
o Sometimes used in combination with ATRA and ATO, particularly in patients with high-risk features or residual disease.
4. Supportive Care:
o Managing Coagulation: Patients may require treatments to manage bleeding and clotting issues, such as blood transfusions or clotting factor replacements.
o Infection Prevention: Due to the risk of infection from low white blood cell counts.
5. Consolidation Therapy:
o Post-remission therapy to ensure that any remaining leukemia cells are eliminated and to prevent relapse. This may include additional courses of ATRA, ATO, or chemotherapy.
Prognosis:
• Generally Favorable: With appropriate treatment, including ATRA and ATO, many patients with APL achieve remission and have a favorable long-term prognosis.
• Risk Factors: Factors such as the presence of bleeding complications, response to initial treatment, and residual disease can affect prognosis.

16/09/2024

Acute Myeloid Leukemia (AML) is a type of cancer that affects the blood and bone marrow, characterized by the rapid proliferation of abnormal myeloid cells. Unlike some other leukemias, AML involves cells that should mature into different types of blood cells but instead remain in an immature state, disrupting normal blood production.
Types of AML:
1. Acute Promyelocytic Leukemia (APL):
o Characteristics: Involves abnormal promyelocytes with distinctive "bundle-of-figs" appearance.
o Treatment: Treated with all-trans retinoic acid (ATRA) and arsenic trioxide.
2. Acute Myelomonocytic Leukemia (AMML):
o Characteristics: Features a mix of myeloid and monocytic cells.
3. Acute Monoblastic Leukemia:
o Characteristics: Primarily involves monoblasts, a type of white blood cell.
4. Acute Erythroid Leukemia:
o Characteristics: Affects erythroid cells, leading to a significant reduction in red blood cell production.
5. Acute Megakaryoblastic Leukemia (AMKL):
o Characteristics: Involves megakaryoblasts, cells that should develop into platelets.
Symptoms:
• General Symptoms: Fatigue, weakness, and fever.
• Hematological Symptoms: Easy bruising, bleeding gums, frequent infections, and anemia.
• Physical Symptoms: Enlarged spleen or liver, bone pain, and swollen lymph nodes.
Diagnosis:
1. Blood Tests:
o Complete Blood Count (CBC): Often shows high white blood cell counts with an increased proportion of blast cells.
o Peripheral Blood Smear: To identify abnormal cells and morphology.
2. Bone Marrow Biopsy:
o Essential for confirming AML and assessing the extent of involvement.
3. Genetic Testing:
o Identifies specific genetic mutations and chromosomal abnormalities, such as FLT3, NPM1, and the presence of the PML-RARA fusion gene in APL.
4. Immunophenotyping:
o Flow Cytometry: Helps classify the subtype of AML by analyzing cell surface markers.
5. Cytogenetic Analysis:
o Examines chromosomes for abnormalities that influence prognosis and treatment options.
6. Lumbar Puncture (Spinal Tap):
o To check for leukemia cells in the cerebrospinal fluid if there is suspected central nervous system involvement.
Treatment:
1. Chemotherapy:
o The main treatment approach, typically involving a combination of drugs administered in several phases:
▪ Induction Therapy: Aims to achieve remission by reducing leukemia cells.
▪ Consolidation Therapy: Further treatment to eliminate residual leukemia cells and prevent relapse.
▪ Maintenance Therapy: Sometimes used to prolong remission.
2. Targeted Therapy:
o Tyrosine Kinase Inhibitors: For mutations like FLT3.
o BCL-2 Inhibitors: For specific subtypes like those with BCL-2 overexpression.
3. Bone Marrow or Stem Cell Transplantation:
o Considered for patients with high-risk AML or those who relapse. It involves replacing diseased bone marrow with healthy stem cells from a donor.
4. Immunotherapy:
o Emerging treatments such as monoclonal antibodies and CAR-T cell therapy may be used in certain cases.
5. Supportive Care:
o Includes managing side effects of treatment, preventing infections, and addressing anemia or bleeding complications.
Prognosis:
• Varies by Factors: Prognosis depends on several factors, including the specific subtype of AML, the patient’s age and overall health, the presence of genetic mutations, and the response to treatment.
• Advances in Treatment: Improvements in treatment and supportive care have enhanced survival rates for many patients.

14/09/2024

Acute Lymphoblastic Leukemia (ALL) is a type of cancer that affects the blood and bone marrow, characterized by the rapid proliferation of immature lymphoblasts (a type of white blood cell). It is the most common type of leukemia in children but can also occur in adults. Here’s a detailed overview of ALL:
Types of Acute Lymphoblastic Leukemia:
1. Pre-B Cell ALL:
o The most common type in children, where the leukemia cells originate from early B lymphoid cells.
2. T-Cell ALL:
o Affects early T lymphoid cells, more common in adolescents and young adults. It can also involve other organs like the thymus.
Symptoms:
• General Symptoms: Fever, fatigue, and weight loss.
• Hematological Symptoms: Anemia (causing pale skin and fatigue), easy bruising, frequent infections, and bleeding (e.g., nosebleeds, bleeding gums).
• Physical Symptoms: Swollen lymph nodes, an enlarged liver or spleen, and bone or joint pain. In some cases, there may be swelling in the chest or neck due to lymph node enlargement.
Diagnosis:
1. Blood Tests:
o Complete Blood Count (CBC): Shows elevated white blood cell count with a high proportion of lymphoblasts.
o Peripheral Blood Smear: Helps identify abnormal cells in the blood.
2. Bone Marrow Biopsy:
o A key diagnostic tool to confirm the presence of leukemia cells in the bone marrow and assess the extent of disease involvement.
3. Genetic Testing:
o Identifies specific genetic mutations and chromosomal abnormalities, such as the Philadelphia chromosome (BCR-ABL fusion) or other genetic markers that influence prognosis and treatment.
4. Immunophenotyping:
o Flow cytometry is used to characterize the types of lymphoblasts and classify the leukemia based on cell surface markers.
5. Lumbar Puncture (Spinal Tap):
o To check for leukemia cells in the cerebrospinal fluid, which can indicate central nervous system involvement.
6. Imaging Studies:
o CT Scans or MRI: To assess for enlarged lymph nodes, spleen, or liver.
Treatment:
1. Chemotherapy:
o The primary treatment for ALL, using a combination of drugs to kill leukemia cells. Treatment typically occurs in several phases:
▪ Induction: Aimed at achieving remission by reducing the number of leukemia cells in the body.
▪ Consolidation: Further treatment to eliminate any remaining leukemia cells and prevent relapse.
▪ Maintenance: Long-term, lower-intensity treatment to maintain remission and prevent recurrence.
2. Targeted Therapy:
o Tyrosine Kinase Inhibitors: For cases with Philadelphia chromosome-positive ALL, such as imatinib.
o Monoclonal Antibodies: Such as blinatumomab, which targets specific leukemia cells.
3. Bone Marrow or Stem Cell Transplantation:
o May be considered for patients at high risk of relapse or those with resistant disease. It involves replacing diseased bone marrow with healthy stem cells from a donor.
4. Immunotherapy:
o CAR-T Cell Therapy: Involves modifying a patient’s T cells to target and destroy leukemia cells. This approach has shown promise for relapsed or refractory cases.
5. Supportive Care:
o Includes managing side effects of treatment, such as infections, anemia, and bleeding, as well as providing supportive therapies like pain management and nutritional support.
Prognosis:
• Varies by Factors: The prognosis for ALL depends on several factors, including the patient’s age, the specific genetic abnormalities present, how well the leukemia responds to treatment, and the overall health of the patient.
• Advances in Treatment: Significant progress in treatment options and supportive care has improved outcomes, with many patients achieving long-term remission or cure.

អត្រានៃអ្នកជម្ងឺមហារីក
12/09/2024

អត្រានៃអ្នកជម្ងឺមហារីក

ที่อยู่

Bankok

เบอร์โทรศัพท์

+66641592864

แจ้งเตือน

รับทราบข่าวสารและโปรโมชั่นของ OncoCamผ่านทางอีเมล์ของคุณ เราจะเก็บข้อมูลของคุณเป็นความลับ คุณสามารถกดยกเลิกการติดตามได้ตลอดเวลา

ติดต่อ การปฏิบัติ

ส่งข้อความของคุณถึง OncoCam:

แชร์